Declaration of competing financial interests : Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer : Nature Reviews Cancer

Jump to main content
Jump to navigation
nature.com homepage
Publications A-Z index
Browse by subject

My account
E-alert sign up
Register
Subscribe

From the following article:

Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer

Rakesh K. Jain

Nature Reviews Cancer 8, 309-316 (April 2008)

doi:10.1038/nrc2346

Declaration: Declaration: Rakesh K. Jain is a consultant and grant recipient of AstraZeneca, a consultant of Dyax and on the scientific advisory board of SynDevRx.